Mark Beer: Co-Founder and Chairman, Renovia Inc.

Marc Beer is among the co-founders of Renovia Inc. He studied at Miami University, where he gained the skills that he has used to steer his company into success. He is extremely dedicated to improving the health of women, a cause that has seen him raise $42 million to fund programs aimed at improvingwomen’s health. Such commitment places him ahead of those who have undertaken essential steps in advancing women’s health globally.

 

Work Experience and World Recognized Undertakings

 

Marc Beer has a vast wealth of experience, owing to the many years he has spent working in medically related fields. He has more than 25 years of experience in the development and commercialization of pharmaceuticals, biotechnology as well as diagnostics. Together with Yolanda Lorie and Ramon Iglesias, they founded Renovia Inc. in 2016. Their promising venture attracted the attention of venture capitalists and angel investors who invested in the company.

 

Marc Beer’s Role at ViaCell

 

Previously, he also held various jobs that played a critical role in making him the successful person that he is today. For instance, he was the founding CEO of ViaCell in April 2010. Marc Beer used his skills and vast experiencethat he had gathered over the years to transform Viacell into a robust and profitable enterprise. The company specialized in the development, preservation, and collection of umbilical cord stem cells.

 

His relentless work at ViaCell can be reflected in the manner in which he led the company to acquire more than 300 employees. Such a hugeworkforce ensured that the company could manage to increase its production capacity and hence increase its revenues. ViaCell finally went public in 2005 and was acquired by PerkinElmer in 2007.

 

Additionally, Marc Beer also held various positions while he was at ViaCell. For instance, he was a member of the board at ErytechPharma. The company specialized in the production of pharmaceuticals. ErytechPharma also had its shares listed in the stock exchange. Some of the senior positions he held are that of Vice President of Global Marketing at Genzyme. That position saw him launch various products that were used to tackle rare diseases worldwide.

 

What’s Behind the $42 million Raised by Marc Beer through his company?

 

Marc Beer, through his company, Renovia Inc., recently announced that they raised over $42 million aimed at tackling health disorders in women. Renovia is currently in its intial stages of developing treatment mechanisms for conditions like urinary incontinence. The condition affects about 250 million women globally. One of their first products that were aimed at treating urinary tract conditions, Leva, was approved by FDA in April. Learn more: https://gazetteday.com/2018/10/marc-beer-funding-renovia/

 

In summary, Marc Beer deserves an accolade for his achievements in the medical and pharmaceutical arena. Renova’s commitment to tackle women’s medical conditions is an excellent step to ensuring the wellbeing of womenfolk in America. Their products will bridge the gap that exists in the medical field especially in women’s health.